Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats

Biomedicine and Pharmacotherapy

Volumn 94, Issue , 2017, Pages 197-205

  Ahmed, Osama M ^a   Hassan, Mohamed A ^a   Abdel Twab, Sanaa M ^a   Abdel Azeem, Manal N ^a  

^a Beni Suef University   (Egypt)

Author keywords

NA STZ diabetes model; Narengenin; Naringin; Navel orange

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIOXIDANT; AURANTIIN; C PEPTIDE; CHOLESTEROL; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NARINGENIN; NAVEL ORANGE PEEL HYDROETHANOLIC EXTRACT; NICOTINAMIDE; PLANT EXTRACT; STREPTOZOCIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; ALCOHOL; FLAVANONE DERIVATIVE; WATER;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; ANALYSIS; ANIMAL; BLOOD; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; FRUIT; GLUCOSE BLOOD LEVEL; ISOLATION AND PURIFICATION; SWEET ORANGE;

ANIMALS; BLOOD GLUCOSE; CITRUS SINENSIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ETHANOL; FLAVANONES; FRUIT; HYPOGLYCEMIC AGENTS; MALE; PLANT EXTRACTS; RATS; STREPTOZOCIN; WATER;

EID: 85026428806     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.07.094     Document Type: Article

References (72)

1. Mahmoud, A.M., Ahmed, O.M., Ashour, M.B., Abdel-Moneim, A., In vivo and in vitro antidiabetic effects of citrus flavonoids; a study on the mechanism of action. Int. J. Diabetes Dev. Ctries. 35:3 (2015), 250–263.
2. Wild, S., Roglic, G., Green, A., Sicree, R., King, H., Global prevalence of diabetes: estimates for theyear 2000 and projections for 2030. Diabetes Care 27:5 (2004), 1047–1053.
3. Cheng, D., Prevalence, predisposition and prevention of type II diabetes. Nutr. Metab. (Lond.), 2, 2005, 29.
4. King, A.J.F., The use of animal models in diabetes research. Br. J. Pharmacol. 166:3 (2012), 877–894.
5. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33:1 (2010), S62–S69.
6. Ghasemi, A., Khalifi, S., Jedi, S., Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol. Hung. 101:4 (2014), 408–420.
7. Bolzán, A.D., Bianchi, M.S., Genotoxicity of streptozotocin. Mutat. Res. 512 (2002), 121–134.
8. Kim, M.J., Ryu, G.R., Chung, J.S., Sim, S.S., Min, D.S., Rhie, D.J., Protective effect of epicatechin against the toxic effects of STZ on rat pancreatic islets: in vivo and in vitro. Pancreas 26 (2003), 292–299.
9. Kumar, G.P.S., Arulselvan, P., Kumar, D.S., Subramanian, S.P., Antidiabetic activity of fruits of Terminalia chebula on streptozotocin induced diabetic rats. J. Health Sci. 52 (2006), 283–291.
10. Turk, J., Corbett, J.A., Ramanadham, S., Bohrer, A., McDaniel, M.L., Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197 (1993), 1458–1464.
11. Eleazu, C.O., Eleazu, K.C., Chukwuma, S., Essien, U.N., Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J. Diabetes Metab. Disord. 12:60 (2013), 1–7.
12. Sheng, T., Yang, K., Adiponectin and its association with insulin resistance and type 2 diabetes. J. Genet. Genomics 35:6 (2008), 321–326.
13. Ruan, H., Dong, L.Q., Adiponectin signaling and function in insulin target tissues. J. Mol. Cell Biol. 2016 (2016), 1–35.
14. Matough, F.A., Budin, S.B., Hamid, Z.A., Ali, N., Mohamed, J., The Role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ. Med. J. 12:1 (2012), 5–18.
15. Fraley, A., Citrus Peel Benefits. 2010, The American University of Washington, DC.
16. Gonzalez-Molina, E., Dominguez-Peries, R., Moreno, C., Garcia-Viguera, C., Natural Bioactive Compounds of Citrus Lemon for Food and Health. 2009, Elsevier, B.V., USA.
17. Manthey, A., Grohmann, K., Phenols in citrus peel by-products. Concentrations of hy droxy cinnamates and poly methoxylated flavones in citrus peel molasses. J. Agric. Food Chem. 49:7 (2001), 3268–3273.
18. Chedea, V.S., Kefalas, P., Socacin, C., Patterns of carotenoid pigments extracted from two orange peel wastes (Valencia and Navel var.). J. Food Biochem. 34:9 (2010), 101–110.
19. Rincon, A.M., Vasquez, A.M., Padilla, F.C., Chemical composition and bioactive compounds of flour of orange (Citrus sinensis), tangerine (Citrus reticulate) and grapefruit (Citrus paradisl) peels cultivated in Venezuela. Arch. Latinoam Nutr. 55:3 (2005), 305–310.
20. Huang, Y.S., Ho, S.C., Poly methoxy flavones are responsible for the antiflammatory activity of citrus fruit peel. Food Chem. 119:3 (2010), 868–873.
21. Xu, C.J., Fraser, P.D., Wang, W.J., Bramley, P.M., Differences in the carotenoid content of ordinary citrus and lycopene-accumulating mutants. J. Agric. Food Chem. 54:12 (2006), 5472–5481.
22. Evans, M., Sharma, P., Guthrie, N., Noreddin, A., (eds.) Bioavailability of Citrus Polymethoxylated Flavones and Their Biological Role in Metabolic Syndrome and Hyperlipidemia, Readings in Advanced Pharmacokinetics- Theory, Methods and Applications, 83/A, 2012, InTech, University Campus STeP Ri Slavka Krautzeka, Rijeka, Croatia, 51000 Available from: http://www.intechopen.com/books/readings-in-advanced-pharmacokinetics-theory-methods-andapplications/the-bioavailability-of-citrus-polymethoxylated-flavones.
23. Ortiz, R.R., Sanchez, S.J.C., Navarrete, V.G., Webster, S.P., Binnie, M., Garcia, J.S., Anti-diabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diab. Obes. Metab. 10 (2008), 1097–1104.
24. Youssef, M.K.E., Youssef, H.M., Mousa, R.M., Evaluation of antihyperglycemic activity of citrus peels powders fortified biscuits in albino induced diabetic rats. Food Public Health 3:3 (2013), 161–167.
25. Ahmed, O.M., Abdel-Moneim, A., Abulyazid, I., Antihyperglycemic, Mahmoud A.M., antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens and rutin in nicotinamide/streptozotocin diabetic albino rats. Diabetol. Croat. 39 (2010), 15–32.
26. Constantin, R.P., Constantin, R.P., Bracht, A., Yamamoto, N.S., Ishii, E.L., Constantin, J., Molecular mechanisms of citrus flavanones on hepatic gluconeogenesis. Fitoterapia 92 (2014), 148–162.
27. Ahmed, O.M., Antihyperglycemic effects of water extract of Ulva lactuca and its polysaccharides in nicotinamide-streptozotocin-induced diabetic rats, Egypt. J. Zool. 54 (2010), 273–297.
28. Ahmed, O.M., Anti-hyperlipidemic, antioxidant and cardiac improving effects of water extract of Ulva lactuca and its polysaccharides in nicotinamide-streptozotocin-induced diabetic rats, Egypt. J. Zool. 54 (2010), 253–272.
29. Trinder, P., Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6 (1969), 24–27.
30. Seifter, S., Dayton, S., Novic, B., Muntwyler, E., The estimation of glycogen with anthrone reagent. Arch. Biochem. 25 (1950), 191–200.
31. Begum, N., Sam, G.P., Shanmugasundaram, K.R., Serum enzymes in human and experimental diabetes mellitus. Indian J. Med. Res. 68 (1978), 774–784.
32. Stalmans, W., Hers, H., The stimulation of liver phosphorylase b by AMP, fluoride and sulphate. A technical note on the specific determination of the a and b forms of liver glycogen phophorylase. Eur. J. Biochem. 54:2 (1975), 341–350.
33. Tietz, N.W., Clinical Guide to Laboratory Tests. 2nd edition, 1990, W.B. Saunders Co., Philadelphia, PA.
34. Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., Fu, P.C., Enzymatic determination of total serum cholesterol. Clin. Chem. 20:4 (1974), 470–475.
35. Friedewald, W.T., Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:7 (1972), 499–502.
36. Nobert, W.T., Clinical Guide to Laboratory Tests. 3rd edition, 1995, Philadelphia, PA: W.B. Saunders Co.
37. Duncombe, W.G., The colorimetric microdetermination of non-esterified fatty acids in plasma. Clin. Chim. Acta 9 (1961), 122–125.
38. Preuss, H.G., Jarrel, S.T., Scheckenbach, R., Lieberman, S., Anderson, R.A., Comparative effects of chromium, vanadium and Gymnema sylvestre on sugar inducedblood pressure elevations in SHR. J. Am. Coll. Nutr. 17:2 (1998), 116–123.
39. Beutler, E., Duron, O., Kelly, B.M., Improved method for determination of blood glutathione. J. Lab. Clin. Med. 61 (1963), 882–888.
40. Matkovics, B., Kotorman, M., Varga, I.S., Hai, D.Q., Vrga, C., Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol. Hung. 85:1 (1997), 29–38.
41. Mannervik, B., Gutenberg, C., Glutathione transferase (human placenta). Methods Enzymol. 77 (1981), 231–235.
42. Chomzynski, P., Sacchi, N., Single step method of RNA isolation by acid guanidinium thiocyanatephenol chloroform extraction. Annu. Rev. Biochem. 162 (1987), 156–159.
43. Boom, R., Sol, C.J., Salimans, M.M., Jansen, C.L., P.M. Wertheim-van Dillen, J. van der Noordaa, Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:3 (1990), 495–503.
44. Sambrook, J., Russell, D.W., Molecular Cloning Laboratory Manual. 5th ed., 2008, Chemical Industry Press, Beijing.
45. Limin, T., Hou, X., Liu, J., Zhang, X., Sun, N., Gao, L., Zhao, J., Chronic ethanol consumption resulting in the downregulation of insulin receptor-beta subunit, insulin receptor substrate-1, and glucose transporter 4 expression in rat cardiac muscles. Alcohol 43:1 (2009), 51–58.
46. Caminos, J.E., Nogueiras, R., Gallego, R., Bravo, S., Tovar, S., Garcıa-Caballero, T., Casanueva, F.F., Dieguez, C., Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90:7 (2005), 4276–4286.
47. Prieto, M.A.V., Bettaieb, A., Lanzi, C.R., Soto, V.C., Perdicaro, D.J., Galmarini, C.R., Haj, F.G., Miatello, R.M., Oteiza, P.I., Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 59:4 (2015), 622–633.
48. Shaker, O.G., Sadik, N.A., Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance. Mol. Cell Biochem. 373 (2013), 229–239.
49. Roa, M., Blane, K., Zonneberg, M., One Way Analysis, Version 1A(C), PC-STAT. 1985, University of Georgia, Athens, USA.
50. Szkudelski, T., Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. (Maywood) 237 (2012), 481–490.
51. Weng, Y., Yu, L., Cui, J., Zhu, R.Z., Guo, C., Wei, G., et al. Antihyperglycemic: hypolipidemic and antioxidant activities of total saponins extracted from Aralia taibaiensis in experimental type 2 diabetic rats. J. Ethnopharmacol. 152 (2014), 553–560.
52. Schaalan, M., El-Abhar, H.S., Barakat, M., El-Denshary, E.S., Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride. J. Diabetes Complicat. 23 (2009), 199–208.
53. Ahmed, O.M., Mahmoud, A.M., Abdel-Moneim, A., Ashour, M.B., Antidiabetic effects of hesperdin and naringin in type 2 diabetic rats. Diabetol. Croat. 41:2 (2012), 53–67.
54. Beck-Nielsen, H., Insulin resistance: organ manifestations and cellular mechanisms. Ugeskr. Laeger 164 (2002), 2130–2135.
55. Gold, A.H., The effect of diabetes and insulin on liver glycogen synthetase activation. J. Biol. Chem. 245 (1970), 903–905.
56. Powers, A.C., Diabetes mellitus. Kasper, D.L., Fauci, A.S., Longo, D.L., Braunwald, E., Hauser, S.L., Jameson, J.L., (eds.) Harrison's Principles of Internal Medicine, 16th ed., 2017, McGraw-Hill Co. Inc., 2005.
57. Song, H., Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., et al. Resistin is regulated by C/EBPs PPARs, and signal-transducing molecules. Biochem. Biophys. Res. Commun. 29 (2002), 291–298.
58. Spranger, J., Kroke, A., Mohlig, M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003), 226–228.
59. Polonsky, K.S., The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:6 (1995), 705–717.
60. Niemeijer-Kanters, S.D., Banga, J.D., Erkelens, D.W., Lipid-lowering therapy in diabetes mellitus. Neth. J. Med. 58 (2001), 214–222.
61. Garber, A.J., Attenuating CV risk factors in patient with diabetes: clinical evidence to clinical practice. Diabetes Obes. Metab. 4:Suppl. (1) (2002), S5–12.
62. Saravanan, R., Pari, L., Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement Altern. Med. 22 (2005), 14–21.
63. Khan, A.N., Khan, R.A., Ahmad, M., Mushtaq, N., Role of antioxidant in oxidative stress and diabetes mellitus. J. Pharmacogn. Phytochem. 3:6 (2015), 217–220.
64. Sugiura, M., Ohshima, M., Ogawa, K., Yano, M., Chronic administration of Satsuma mandarin fruit improves oxidative stress in streptozotocin induced diabetic rat liver. Biol. Pharmacol. Bull. 29 (2006), 588–591.
65. Singh, K.S., Tripathi, M., Bhatnagar, P., Kakkar, P., Gupta, K.C., O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes. PLoS One, 9(2), 2014, e89124.
66. Zhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Hemeoxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS One, 8(9), 2013, e75927.
67. Ali, M.M., Abd El-Kader, M.A., The influence of naringin on the oxidative state of rats with streptozotocin-induced acute hyperglycaemia. Zeitschriftfur Naturforschung Section C 59:9–10 (2004), 726–733.
68. Murray, R.K., Granner, D.K., Mayes, P.A., Rodwell, V.W., Harper’ Biochemistry. 25th ed., 2000, Appleton and Lange, Stanford, CT.
69. Kapoor, R., Kakkar, P., Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade. Toxicol. Rep. 1 (2014), 569–581.
70. Yamauchi, T., Kamon, J., Waki, H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001), 941–946.
71. Kim, J.Y., Scherer, P.E., Adiponectin, an adipocyte-derived hepatic insulin sensitizer regulation during development. Pediatr. Endocrinol. Rev. 1:Suppl (3) (2004), 428–431.
72. Zorzano, A., Santalucia, A., Palacín, M., Guma, A., Camps, M., Searching for ways to upregulate GLUT4 glucose transporter expression in muscle. Gen. Pharmacol. 31 (1998), 705–713.